5QC4 | pdb_00005qc4

Crystal structure of human Cathepsin-S with bound ligand


Experimental Data Snapshot

  • Method: X-RAY DIFFRACTION
  • Resolution: 2.00 Å
  • R-Value Free: 
    0.210 (Depositor), 0.212 (DCC) 
  • R-Value Work: 
    0.152 (Depositor), 0.154 (DCC) 
  • R-Value Observed: 
    0.155 (Depositor) 

wwPDB Validation 3D Report Full Report

Validation slider image for 5QC4

Ligand Structure Quality Assessment 


This is version 2.3 of the entry. See complete history

Literature

Thioether acetamides as P3 binding elements for tetrahydropyrido-pyrazole cathepsin S inhibitors.

Wiener, D.K.Lee-Dutra, A.Bembenek, S.Nguyen, S.Thurmond, R.L.Sun, S.Karlsson, L.Grice, C.A.Jones, T.K.Edwards, J.P.

(2010) Bioorg Med Chem Lett 20: 2379-2382

  • DOI: https://doi.org/10.1016/j.bmcl.2010.01.103
  • Primary Citation Related Structures: 
    5QC4

  • PubMed Abstract: 

    A series of tetrahydropyrido-pyrazole cathepsin S (CatS) inhibitors with thioether acetamide functional groups were prepared with the goal of improving upon the cellular activity of amidoethylthioethers. This Letter describes altered amide connectivity, in conjunction with changes to other binding elements, resulting in improved potency, as well as increased knowledge of the relationship between this chemotype and human CatS activity.


  • Organizational Affiliation
    • Johnson & Johnson Pharmaceutical Research & Development, L.L.C., 3210 Merryfield Row, San Diego, CA 92121, United States. dwiener@its.jnj.com

Macromolecule Content 

  • Total Structure Weight: 50.34 kDa 
  • Atom Count: 4,037 
  • Modeled Residue Count: 441 
  • Deposited Residue Count: 446 
  • Unique protein chains: 1

Macromolecules

Find similar proteins by:|  3D Structure
Entity ID: 1
MoleculeChains  Sequence LengthOrganismDetailsImage
Cathepsin S
A, B
223Homo sapiensMutation(s): 1 
Gene Names: CTSS
EC: 3.4.22.27
UniProt & NIH Common Fund Data Resources
Find proteins for P25774 (Homo sapiens)
Explore P25774 
Go to UniProtKB:  P25774
PHAROS:  P25774
GTEx:  ENSG00000163131 
Entity Groups
Sequence Clusters30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity
UniProt GroupP25774
Sequence Annotations
Expand
Reference Sequence

Small Molecules

Ligands 1 Unique
IDChains Name / Formula / InChI Key2D Diagram3D Interactions
BC7

Query on BC7



Download:Ideal Coordinates CCD File
C [auth A],
D [auth B]
2-[5-[5-ethanoyl-1-[(2~{R})-2-oxidanyl-3-[4-(2-oxidanylpropan-2-yl)piperidin-1-yl]propyl]-6,7-dihydro-4~{H}-pyrazolo[4,3-c]pyridin-3-yl]-2-(trifluoromethyl)phenyl]sulfanyl-1-pyrrolidin-1-yl-ethanone
C32 H44 F3 N5 O4 S
QMRXULKWYQUBRF-XMMPIXPASA-N

Experimental Data & Validation

Experimental Data

  • Method: X-RAY DIFFRACTION
  • Resolution: 2.00 Å
  • R-Value Free:  0.210 (Depositor), 0.212 (DCC) 
  • R-Value Work:  0.152 (Depositor), 0.154 (DCC) 
  • R-Value Observed: 0.155 (Depositor) 
Space Group: P 1
Unit Cell:
Length ( Å )Angle ( ˚ )
a = 37.02α = 70.75
b = 52.97β = 71.79
c = 58.58γ = 73.21
Software Package:
Software NamePurpose
PHENIXrefinement
PDB_EXTRACTdata extraction
MOSFLMdata reduction
SCALAdata scaling

Structure Validation

View Full Validation Report



Ligand Structure Quality Assessment 


Entry History 

Deposition Data

Revision History  (Full details and data files)

  • Version 1.0: 2017-12-20
    Type: Initial release
  • Version 1.1: 2018-02-21
    Changes: Structure summary
  • Version 2.0: 2018-06-06
    Changes: Atomic model, Data collection, Refinement description, Structure summary
  • Version 2.1: 2021-02-10
    Changes: Structure summary
  • Version 2.2: 2021-11-17
    Changes: Database references, Structure summary
  • Version 2.3: 2024-11-13
    Changes: Data collection, Structure summary